In conclusion, miR-326 inhibited SIRT1 expression to repress HIF1α and elevate VEGFA in order to reduce chemotherapy resistance, thereby suppressing the development of NSCLC. The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.